Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-09-30

FDA Approved: ZIAGEN — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

The FDA approved a supplemental application for Ziagen (abacavir sulfate) submitted by ViiV Healthcare Company, resulting in updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziagen (Abacavir)

Snippet

SUPPL AP for ZIAGEN (ABACAVIR SULFATE)